REGENCOR INC
Healing a broken heart, quite literally
SAN CARLOS, United States · Founded 2018 · $3.9M raised
- Headquarters
- SAN CARLOS, California
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- regencor.com
- Total Funding
- $3.9M
- Last Round
- $3.9M GrantNov 2021
- Rounds
- 2
About
Regencor is a regenerative medicine company developing therapeutics to repair cardiac tissue damage and restore heart function after myocardial infarction. Its lead asset REG101 (recombinant FSTL1 protein) reverses scar tissue formation and is being developed in two delivery formulations — MyoBeads for acute MI intervention and Q-Beads for subcutaneous administration in heart failure patients.
Summary
REGENCOR INC is a Biotech company based in SAN CARLOS, United States, founded in 2018. It has raised $3.9M in total across 2 rounds, most recently a $3.9M Grant round in Nov 2021. Investors include California Institute for Regenerative Medicine and Amgen.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...